Results 251 to 260 of about 2,678,192 (313)
Some of the next articles are maybe not open access.

Catalytic Antibodies

Current Opinion in Chemical Biology, 1998
Following the end of the first decade in catalytic antibody research, recent efforts are reflecting a more introspective view of the field. Notably, X-ray crystal structure analyses of antibody catalysts are permitting an increased understanding of the evolution and modus operandi of these remarkable biocatalysts. Additionally, the breadth and scope of
P, Wentworth, K D, Janda
openaire   +2 more sources

Antibodies and Selection of Monoclonal Antibodies

2015
Monoclonal antibodies are universal binding molecules with a high specificity for their target and are indispensable tools in research, diagnostics and therapy. The biotechnological generation of monoclonal antibodies was enabled by the hybridoma technology published in 1975 by Köhler and Milstein.
Katja, Hanack   +2 more
openaire   +2 more sources

Computational Analysis of Antibody Paratopes for Antibody Sequences in Antibody Libraries

2022
To ensure the functionalities of the antibodies in phage-displayed synthetic antibody libraries, we use computational method to evaluate the designs of the antibody libraries. The computational methodologies developed in our lab for designing antibody library provide rich information on the function of the designed antibody sequences-adequate antibody ...
Hung-Pin, Peng, An-Suei, Yang
openaire   +2 more sources

Phage antibodies: will new ‘coliclonal’ antibodies replace monoclonal antibodies?

Trends in Biotechnology, 1992
Antibodies can now be rapidly isolated from large and diverse recombinant libraries by displaying functional antibody fragments on the surface of bacteriophage particles and directly selecting with antigen. This method has been used to isolate antibodies, including human antibodies, with and without immunization, and to improve the affinity and ...
D J, Chiswell, J, McCafferty
openaire   +2 more sources

Antibodies in proteomics I: generating antibodies

Trends in Biotechnology, 2003
The explosion in genome sequencing, and in subsequent DNA array experiments, has provided extensive information on gene sequence, organization and expression. This has resulted in a desire to perform similarly broad experiments on all the proteins encoded by a genome.
BRADBURY A.   +9 more
openaire   +3 more sources

Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology

Recent Patents on Anti-Cancer Drug Discovery, 2020
Background: The therapeutic outcomes and the prognosis of patients with various hematologic malignancies are not always ideal with the current standard of care. Objective: The aim of this study is to analyze the results of the use of monoclonal antibodies, bispecific antibodies and antibody-drug conjugates for the therapy of malignant hemopathies.
openaire   +2 more sources

Antibody and antibody derivatives as cancer therapeutics

WIREs Nanomedicine and Nanobiotechnology, 2019
Antibodies are an important class of therapeutic for treating a wide range of diseases. These versatile macromolecules can be engineered to target many different antigens and to utilize several mechanisms of action to produce a pharmacological effect. The most common antibody platform used for therapeutics is immunoglobulin G (IgG). Advances in protein‐
Keith J, Arlotta, Shawn C, Owen
openaire   +2 more sources

Antiphospholipid antibody and antiphospholipid antibody syndrome

Current Opinion in Rheumatology, 1991
New details have been added to the description of the antiphospholipid antibody syndrome. These include quantitation of risk of stroke; delineation of an associated acute occlusive vasculopathy syndrome, including its pathology; increased awareness of the association of adrenal insufficiency with antiphospholipid antibody; new demonstration of ...
openaire   +2 more sources

ANTIBODIES

2021
KOOPMAN LOUISE   +8 more
openaire   +6 more sources

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Shanu Modi   +2 more
exaly  

Home - About - Disclaimer - Privacy